Cargando…

Effect of Combined Sorafenib/Cisplatinum Treatment on the Autophagy and Proliferation of Hepatocellular Carcinoma hepG2 Cells in Vitro

OBJECTIVE: To explore the effect of combined Sorafenib/ cisplatinum treatment on the autophagy and proliferation of hepatocellular carcinoma (HepG2) cells in vitro. METHODS: HepG2 cells were cultured and treated with different concentrations of Sorafenib, cisplatinum, or a combination of both over a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yaoting, Wang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798144/ https://www.ncbi.nlm.nih.gov/pubmed/33112540 http://dx.doi.org/10.31557/APJCP.2020.21.10.2853

Ejemplares similares

Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
por: Taha, Amna Mohamed, et al.
Publicado: (2022)

Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2018)

Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy
por: Miao, Qing, et al.
Publicado: (2013)

miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line
por: Kaur, Ramanpreet, et al.
Publicado: (2022)

Inducible T-cell co-stimulators regulate the proliferation and invasion of human hepatocellular carcinoma HepG2 cells
por: Wei, Yaning, et al.
Publicado: (2018)

Dihydroartemisinin inhibits HepG2.2.15 proliferation by inducing cellular senescence and autophagy
por: Zou, Jiang, et al.
Publicado: (2019)

PP4R1 accelerates cell growth and proliferation in HepG2 hepatocellular carcinoma
por: Wu, Gang, et al.
Publicado: (2015)

A secretome profile indicative of oleate-induced proliferation of HepG2 hepatocellular carcinoma cells
por: Park, Soyeon, et al.
Publicado: (2018)

Silencing of the TROP2 gene suppresses proliferation and invasion of hepatocellular carcinoma HepG2 cells
por: Zhang, Jian, et al.
Publicado: (2019)

PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelial-mesenchymal transition
por: Liu, Hongyu, et al.
Publicado: (2019)

Decreased Expression of GATA2 Promoted Proliferation, Migration and Invasion of HepG2 In Vitro and Correlated with Poor Prognosis of Hepatocellular Carcinoma
por: Li, Yi-Wei, et al.
Publicado: (2014)

Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
por: Rao, Qi, et al.
Publicado: (2022)

Embelin-induced apoptosis of HepG2 human hepatocellular carcinoma cells and blockade of HepG2 cells in the G2/M phase via the mitochondrial pathway
por: TAGHIYEV, ASAF, et al.
Publicado: (2012)

Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro
por: Mochalski, Paweł, et al.
Publicado: (2013)

PP4R1 Accelerates Cell Growth and Proliferation in HepG2 Hepatocellular Carcinoma [Retraction]
Publicado: (2023)

Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells
por: Liu, Jie, et al.
Publicado: (2016)

RY10-4 Inhibits the Proliferation of Human Hepatocellular Cancer HepG2 Cells by Inducing Apoptosis In Vitro and In Vivo
por: Zhang, Xuenong, et al.
Publicado: (2016)

The effects and mechanism of peiminine-induced apoptosis in human hepatocellular carcinoma HepG2 cells
por: Chao, Xu, et al.
Publicado: (2019)

Effects of Metformin Combined With Antifolates on HepG2 Cell Metabolism and Cellular Proliferation
por: Tawfik, Sherouk M., et al.
Publicado: (2022)

PP4R1 Accelerates Cell Growth and Proliferation in HepG2 Hepatocellular Carcinoma [Expression of Concern]
Publicado: (2020)

Antiproliferative and Apoptotic Effects of Cardamonin against Hepatocellular Carcinoma HepG2 Cells
por: Badroon, Nassrin A., et al.
Publicado: (2020)

Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy
por: Li, Jun, et al.
Publicado: (2018)

Effects of Genistein and Synergistic Action in Combination with Tamoxifen on the HepG2 Human Hepatocellular Carcinoma Cell Line
por: Sanaei, Masumeh, et al.
Publicado: (2017)

Ototoxicity of cisplatinum.
por: Brock, P., et al.
Publicado: (1991)

Downregulation of ADAM10 Expression Inhibits Metastasis and Invasiveness of Human Hepatocellular Carcinoma HepG2 Cells
por: Yue, Yuan, et al.
Publicado: (2013)

High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo
por: Xiao, Yinzong, et al.
Publicado: (2017)

The Effect of Alpha Mangostin on Epithelial-Mesenchymal Transition on Human Hepatocellular Carcinoma HepG2 Cells Surviving Sorafenib via TGF-β/Smad Pathways
por: Adenina, Syarinta, et al.
Publicado: (2020)

Effects of Sinapic Acid Combined with Cisplatin on the Apoptosis and Autophagy of the Hepatoma Cells HepG2 and SMMC-7721
por: Zhao, Jian, et al.
Publicado: (2021)

Downregulation of HBx Restrains Proliferation, Migration, and Invasion of HepG2 Cells
por: Huang, Chaoqun, et al.
Publicado: (2021)

Ethanol Extract of Dianthus chinensis L. Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells In Vitro
por: Nho, Kyoung Jin, et al.
Publicado: (2012)

Apoptotic and Inhibitory Effects on Cell Proliferation of Hepatocellular Carcinoma HepG2 Cells by Methanol Leaf Extract of Costus speciosus
por: Nair, Sandhya V. G., et al.
Publicado: (2014)

S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway
por: Wu, Rui, et al.
Publicado: (2023)

Exenatide induces autophagy and prevents the cell regrowth in HepG2 cells
por: Krause, Gabriele Catyana, et al.
Publicado: (2019)

Effect of DNA Methyltransferase in Comparison to and in Combination with Histone Deacetylase Inhibitors on Hepatocellular Carcinoma HepG2 Cell Line
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Effective Inhibition of Xenografts of Hepatocellular Carcinoma (HepG2) by Rapamycin and Bevacizumab in an Intrahepatic Model
por: Ong, Lai-Chun, et al.
Publicado: (2009)

Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, “Naked” Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells
por: Varlamova, Elena G., et al.
Publicado: (2022)

Aleuritolic Acid Impaired Autophagic Flux and Induced Apoptosis in Hepatocellular Carcinoma HepG2 Cells
por: Yi, Hua, et al.
Publicado: (2018)

Effect of Spheroidal Age on Sorafenib Diffusivity and Toxicity in a 3D HepG2 Spheroid Model
por: Eilenberger, Christoph, et al.
Publicado: (2019)

Characterization of In Vitro 3D Cell Model Developed from Human Hepatocellular Carcinoma (HepG2) Cell Line
por: Štampar, Martina, et al.
Publicado: (2020)

Chenodeoxycholic Acid Enhances the Effect of Sorafenib in Inhibiting HepG2 Cell Growth Through EGFR/Stat3 Pathway
por: Zhang, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vfgorenpaa1t1k8fimsqq2muph